| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 543.172 | 595.470 | 51.066 | 21.977 |
| Total Income - EUR | - | - | - | - | - | - | 543.173 | 596.768 | 51.325 | 22.033 |
| Total Expenses - EUR | - | - | - | - | - | - | 5.949 | 26.914 | 27.936 | 45.703 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 537.224 | 569.853 | 23.389 | -23.669 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 531.792 | 564.613 | 22.945 | -23.889 |
| Employees | - | - | - | - | - | - | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Reference Laboratories S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | - | - | 643.467 | 631.516 | 215.161 | 84.329 |
| Inventories | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | - | 51 | 93 | 467 | 1.395 |
| Cash | - | - | - | - | - | - | 643.416 | 631.423 | 214.694 | 82.933 |
| Shareholders Funds | - | - | - | - | - | - | 533.814 | 598.573 | 62.110 | 37.874 |
| Social Capital | - | - | - | - | - | - | 2.022 | 2.028 | 2.022 | 2.010 |
| Debts | - | - | - | - | - | - | 109.653 | 32.943 | 153.051 | 46.454 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7320 - 7320" | |||||||||
| CAEN Financial Year |
7112
|
|||||||||
Comments - Reference Laboratories S.r.l.